Sab Biotherapeutics Stock Forecast

Buy or Hold candidate since Jul 21, 2026 Loss -1.65%

The SAB Biotherapeutics, Inc. stock price fell by -1.65% on the last day (Wednesday, 22nd Jul 2026) from $3.64 to $3.58. During the last trading day the stock fluctuated 2.98% from a day low at $3.53 to a day high of $3.63. The price has fallen in 6 of the last 10 days and is down by -5.04% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -613 thousand shares and in total, 179 thousand shares were bought and sold for approximately $642.31 thousand.

The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect SAB Biotherapeutics, Inc. stock with a 90% probability to be traded between $3.41 and $4.11 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

SABS Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, July 20, 2026, and so far it has risen 1.99%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The SAB Biotherapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.59 and $3.69. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for SAB Biotherapeutics, Inc. stock

SAB Biotherapeutics, Inc. finds support from accumulated volume at $3.56 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.105 between high and low, or 2.98%. For the last week the stock has had daily average volatility of 4.55%.

Our recommended stop-loss: $3.38 (-5.54%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 2 days ago.)

Trading Expectations (SABS) For The Upcoming Trading Day Of Thursday 23rd

For the upcoming trading day on Thursday, 23rd we expect SAB Biotherapeutics, Inc. to open at $3.58, and during the day (based on 14 day Average True Range), to move between $3.48 and $3.68, which gives a possible trading interval of +/-$0.201 (+/-5.77%) up or down from last closing price. If SAB Biotherapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 5.77% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.56 (0.56%) than the resistance at $3.80 (6.15%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is SAB Biotherapeutics, Inc. stock A Buy?

SAB Biotherapeutics, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: -0.457 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 23, 2026 - $3.58 ( 0.0466%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk